Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
1
1
1
1
0
--
Research & Development
--
--
--
--
--
--
Operating Expenses
1
1
1
1
0
--
Other Non Operating Income (Expenses)
0
0
0
0
--
--
Pretax Income
-1
0
1
0
0
--
Income Tax Expense
0
0
0
0
--
--
Net Income
-2
0
1
0
0
--
Net Income Growth
--
-100%
--
--
--
--
Shares Outstanding (Diluted)
3.66
5.87
9.2
14.95
14.95
--
Shares Change (YoY)
-39%
-36%
-38%
0%
--
--
EPS (Diluted)
-0.55
-0.16
0.14
0.02
-0.01
--
EPS Growth
886.99%
-216%
618%
-300%
--
--
Free Cash Flow
0
-2
-1
0
0
--
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
--
--
--
--
--
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
--
Free Cash Flow Margin
0%
0%
0%
0%
0%
--
EBITDA
--
--
--
--
--
--
EBITDA Margin
--
--
--
--
--
--
D&A For EBITDA
--
--
--
--
--
--
EBIT
-1
-1
-1
-1
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
--
--
Follow-Up Questions
What are Alps Group Inc's key financial statements?
According to the latest financial statement (Form-10K), Alps Group Inc has a total asset of $3, Net loss of $0
What are the key financial ratios for GLLIU?
Alps Group Inc's Current ratio is 0.27, has a Net margin is 0, sales per share of $0.
How is Alps Group Inc's revenue broken down by segment or geography?
Alps Group Inc largest revenue segment is Chain, at a revenue of 94,254,000,000 in the most earnings release.For geography, Japan is the primary market for Alps Group Inc, at a revenue of 96,745,000,000.
Is Alps Group Inc profitable?
no, according to the latest financial statements, Alps Group Inc has a net loss of $0
Does Alps Group Inc have any liabilities?
yes, Alps Group Inc has liability of 11
How many outstanding shares for Alps Group Inc?
Alps Group Inc has a total outstanding shares of 3.72
Key Stats
Prev.Close
$3.35
Open
$4.2
Day's Range
$3.05 - $4.2
52 week range
$0.5622 - $15
Volume
450
Avg.Volume
297.3K
Dividend yield
--
EPS (TTM)
-0.51
Market Cap
$525.9M
What is GLLIU?
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.